Literature DB >> 2636045

Synthesis, structure, and conformation of the dilactone derivative of GD1b ganglioside.

G Fronza1, G Kirschner, D Acquotti, S Sonnino.   

Abstract

Treatment of DG1b, beta-Gal-(1----3)-beta-GalNAc-(1---- 4)-[alpha-Neu5Ac-(2----8)-alpha-Neu5Ac-(2---- 3)]-beta-Gal-(1----4)-beta-Glc-(1----1)-Cer, with dicyclohexylcarbodi-imide in anhydrous methyl sulfoxide affords 95-98% of GD1b-dilactone. The carboxyl groups of the two sialic acid units are involved in ester linkages, as proved by ammoniolysis and reduction which gave derivatives containing the amide of sialic acid and N-acetylneuraminulose, respectively. 1H-N.m.r. spectroscopy showed that the lactone rings involved position 9 of the inner sialic acid and position 2 of the inner galactose and that the disialosyl chain is extended toward the -beta-Gal-(1 ----4)-beta-Glc- portion of the ganglioside moiety.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2636045     DOI: 10.1016/0008-6215(89)85087-6

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  4 in total

1.  A procedure for the preparation of GM3 ganglioside from GM1-lactone.

Authors:  L Mauri; R Casellato; G Kirschner; S Sonnino
Journal:  Glycoconj J       Date:  1999-03       Impact factor: 2.916

2.  Unique disialosyl gangliosides from salmon kidney: characterization of V3alphaFuc, IV3betaGalNAc, II3(alphaNeuAc)2-Gg4Cer and its analogue with 4-O-acetyl-N-acetylneuraminic acid.

Authors:  Yukio Niimura; Ineo Ishizuka
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 3.009

3.  Individual Restriction Of Fine Specificity Variability In Anti-GM1 IgG Antibodies Associated With Guillain-Barré Syndrome.

Authors:  Ricardo D Lardone; Nobuhiro Yuki; Fernando J Irazoqui; Gustavo A Nores
Journal:  Sci Rep       Date:  2016-01-28       Impact factor: 4.379

Review 4.  Intramolecular Lactones of Sialic Acids.

Authors:  Paola Rota; Paolo La Rocca; Pietro Allevi; Carlo Pappone; Luigi Anastasia
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.